Ovid Therapeutics has filed to offer up to $250 million in securities, signaling growth plans in the pharmaceutical sector.
| Name | Ovid Therapeutics Inc. |
|---|---|
| CIK | 0001636651 |
| Tickers | OVID |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 465270895 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 212-776-4381 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Ovid Therapeutics has filed to offer up to $250 million in securities, signaling growth plans in the pharmaceutical sector.
Ovid Therapeutics shares its Q3 results, emphasizing pipeline advancements and financial metrics, reflecting its position in the competitive pharmaceutical sector.
Ovid Therapeutics Inc. announces Q3 2026 financial results, highlighting progress in its epilepsy drug pipeline, including OV329 and OV4071.
538 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003565 | 333-299946 | 261567925 | 33 | 1724 | ||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128698 | 005-90350 | 261563699 | 34 | 11921 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000289 | 005-90350 | 261562875 | 34 | 15032 | |||
| 2026-11-10 | S-3 | S-3 | 0001193125-26-454506 | 333-299946 | 261538115 | 33 | 1333203 | 1 | 1 | |
| 2026-11-10 | 10-Q | 10-Q | 0001628280-26-072495 | 001-38085 | 261537909 | 34 | 18168515 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-072494 | 001-38085 | 261537893 | 34 | 247059 | 1 | 1 |
| 2026-08-24 | 144 | xsl144X01/primary_doc.xml | 0001311404-26-000007 | 001-38085 | 261311225 | 33 | 6635 | |||
| 2026-08-14 | 144 | xsl144X01/primary_doc.xml | 0001311404-26-000005 | 001-38085 | 261284178 | 33 | 10433 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097342 | 005-90350 | 261283531 | 34 | 13877 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000926 | 005-90350 | 261283075 | 34 | 15527 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001580642-26-005303 | 005-90350 | 261278173 | 34 | 12247 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003432 | 005-90350 | 261275839 | 34 | 15870 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000510 | 005-90350 | 261273302 | 34 | 10192 | |||
| 2026-08-13 | 10-Q | 10-Q | 0001628280-26-056498 | 001-38085 | 261270210 | 34 | 9795357 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 9.01 | 0001628280-26-056497 | 001-38085 | 261270206 | 34 | 246735 | 1 | 1 |
| 2026-07-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002922 | 005-90350 | 261216981 | 34 | 10763 | |||
| 2026-07-08 | 4 | xslF345X06/form4-07082026_080741.xml | 0001779359-26-000004 | 5158 | ||||||
| 2026-07-08 | 3 | xslF345X06/form3-07082026_080713.xml | 0001779359-26-000002 | 12309 | ||||||
| 2026-07-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001623632-26-000990 | 005-90350 | 261160780 | 34 | 45771 | |||
| 2026-07-08 | 8-K | 8-K | 5.02 | 0001628280-26-047584 | 001-38085 | 261160752 | 34 | 149911 | 1 | 1 |
| 2026-06-17 | 4 | xslF345X06/form4-06172026_080618.xml | 0002138163-26-000005 | 5565 | ||||||
| 2026-06-17 | 3 | xslF345X06/form3-06172026_080636.xml | 0002138163-26-000003 | 8485 | ||||||
| 2026-06-11 | 8-K | 8-K | 5.07 | 0001628280-26-042396 | 001-38085 | 261081584 | 34 | 154345 | 1 | 1 |
| 2026-06-03 | 8-K | 8-K | 5.02 | 0001628280-26-040038 | 001-38085 | 261058901 | 34 | 146090 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003481 | 005-90350 | 26988079 | 34 | 13354 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001580642-26-003200 | 005-90350 | 26984519 | 34 | 15260 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003209 | 005-90350 | 26982401 | 34 | 17401 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-225184 | 005-90350 | 26982019 | 34 | 127416 | |||
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001256153-26-000006 | 005-90350 | 26979482 | 34 | 7044 | |||
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000317 | 005-90350 | 26979215 | 34 | 9739 | |||
| 2026-05-12 | 10-Q | 10-Q | 0001628280-26-033864 | 001-38085 | 26965843 | 34 | 8670180 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 9.01 | 0001628280-26-033859 | 001-38085 | 26965825 | 34 | 245662 | 1 | 1 |
| 2026-04-27 | ARS | ARS | 0001628280-26-027625 | 001-38085 | 26901979 | 34 | 17964299 | |||
| 2026-04-27 | DEFA14A | DEFA14A | 0001628280-26-027624 | 001-38085 | 26901971 | 34 | 721602 | 1 | 1 | |
| 2026-04-27 | DEF 14A | DEF 14A | 0001628280-26-027621 | 001-38085 | 26901966 | 34 | 2677412 | 1 | 1 | |
| 2026-04-27 | 424B3 | 424B3 | 0001193125-26-182352 | 333-295218 | 26901883 | 33 | 156745 | |||
| 2026-04-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001333 | 333-295218 | 26896320 | 33 | 1723 | ||
| 2026-04-23 | CORRESP | filename1.htm | 0001193125-26-174064 | 7334 | ||||||
| 2026-04-23 | UPLOAD | filename1.pdf | 0000000000-26-004178 | 333-295218 | 148884 | |||||
| 2026-04-21 | S-3 | S-3 | 0001193125-26-166974 | 333-295218 | 26879965 | 33 | 397446 | 1 | 1 | |
| 2026-04-20 | 8-K | 8-K | 8.01 | 0001628280-26-025926 | 001-38085 | 26873426 | 34 | 140995 | 1 | 1 |
| 2026-04-09 | 4 | xslF345X06/form4-04092026_050404.xml | 0001202098-26-000004 | 5237 | ||||||
| 2026-04-09 | 4 | xslF345X06/form4-04092026_050403.xml | 0001368324-26-000004 | 5267 | ||||||
| 2026-04-09 | 4 | xslF345X06/form4-04092026_050401.xml | 0001886431-26-000004 | 5238 | ||||||
| 2026-03-25 | 4 | xslF345X06/form4-03262026_010323.xml | 0001256153-26-000004 | 8121 | ||||||
| 2026-03-18 | S-8 | S-8 | 0001628280-26-019463 | 333-294418 | 26770025 | 33 | 678874 | 1 | 1 | |
| 2026-03-18 | 10-K | 10-K | 0001628280-26-019438 | 001-38085 | 26769481 | 34 | 30053586 | 1 | 1 | |
| 2026-03-18 | 8-K | 8-K | 1.01,2.02,3.02,9.01 | 0001628280-26-019045 | 001-38085 | 26765319 | 34 | 27808399 | 1 | 1 |
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040303.xml | 0002036798-26-000004 | 7989 | ||||||
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040315.xml | 0001202098-26-000002 | 5379 | ||||||
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040313.xml | 0001886431-26-000002 | 5383 | ||||||
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040301.xml | 0001256153-26-000002 | 5427 | ||||||
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040311.xml | 0001368324-26-000002 | 5407 | ||||||
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040309.xml | 0001353128-26-000002 | 5482 | ||||||
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040307.xml | 0001654055-26-000002 | 5385 | ||||||
| 2026-03-02 | 4 | xslF345X05/form4-03022026_040305.xml | 0001311404-26-000002 | 9973 | ||||||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-016662 | 005-90350 | 26644810 | 34 | 17854 | |||
| 2026-01-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001315863-26-000096 | 005-90350 | 26579978 | 34 | 14914 | |||
| 2026-01-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001623632-26-000052 | 005-90350 | 26518252 | 34 | 45561 | |||
| 2026-01-05 | 4 | xslF345X05/form4-01052026_050101.xml | 0002036798-26-000002 | 5536 | ||||||
| 2026-01-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-000036 | 005-90350 | 26506155 | 34 | 18872 | |||
| 2025-12-22 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003891 | 333-292151 | 251594572 | 33 | 1724 | ||
| 2025-12-22 | 424B3 | 424B3 | 0001193125-25-328805 | 333-292151 | 251592821 | 33 | 184439 | |||
| 2025-12-19 | CORRESP | filename1.htm | 0001193125-25-327040 | 7064 | ||||||
| 2025-12-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-25-000079 | 005-90350 | 251584494 | 34 | 19685 | |||
| 2025-12-18 | 4 | xslF345X05/form4-12182025_041203.xml | 0001256153-25-000004 | 15759 | ||||||
| 2025-12-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001315863-25-000859 | 005-90350 | 251583087 | 34 | 13732 | |||
| 2025-12-18 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-323798 | 001-38085 | 251581396 | 34 | 174435 | 1 | 1 |
| 2025-12-15 | S-3 | S-3 | 0001193125-25-319453 | 333-292151 | 251572599 | 33 | 416579 | 1 | 1 | |
| 2025-12-11 | 8-K | 8-K | 5.07 | 0001636651-25-000017 | 001-38085 | 251564450 | 34 | 154252 | 1 | 1 |
| 2025-12-09 | 4 | FORM 4 | 0001395064-25-000172 | 10203 | ||||||
| 2025-12-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001395064-25-000167 | 005-90350 | 251560620 | 34 | 20587 | |||
| 2025-12-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000340 | 005-90350 | 251555166 | 34 | 9861 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001636651-25-000012 | 001-38085 | 251468681 | 34 | 7514932 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,5.02,9.01 | 0001636651-25-000011 | 001-38085 | 251468655 | 34 | 267401 | 1 | 1 |
| 2025-11-07 | DEF 14A | DEF 14A | 0001140361-25-040884 | 001-38085 | 251460274 | 34 | 1796843 | |||
| 2025-10-28 | PRE 14A | PRE 14A | 0001140361-25-039516 | 001-38085 | 251421156 | 34 | 1680700 | |||
| 2025-10-27 | PREM14A | PREM14A | 0001140361-25-039497 | 001-38085 | 251420735 | 34 | 1678943 | |||
| 2025-10-03 | 8-K | 8-K | 1.01,3.02,5.03,8.01,9.01 | 0001193125-25-230409 | 001-38085 | 251374919 | 34 | 1166306 | 1 | 1 |
| 2025-09-16 | 8-K | 8-K | 8.01 | 0001193125-25-204308 | 001-38085 | 251315855 | 34 | 134620 | 1 | 1 |
| 2025-08-13 | 10-Q | 10-Q | 0001628280-25-040008 | 001-38085 | 251209053 | 34 | 7272721 | 1 | 1 | |
| 2025-08-13 | 8-K | 8-K | 9.01 | 0001628280-25-040007 | 001-38085 | 251209049 | 34 | 258758 | 1 | 1 |
| 2025-07-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-002008 | 005-90350 | 251138286 | 34 | 19750 | |||
| 2025-07-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003245 | 005-90350 | 251132365 | 34 | 10682 | |||
| 2025-07-10 | 8-K | 8-K | 5.07 | 0001628280-25-034733 | 001-38085 | 251116593 | 34 | 160131 | 1 | 1 |
| 2025-07-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-066702 | 005-90350 | 251113691 | 34 | 10247 | |||
| 2025-06-25 | 8-K | 8-K | 8.01 | 0001628280-25-032959 | 001-38085 | 251071096 | 34 | 209575 | 1 | 1 |
| 2025-06-18 | 4 | xslF345X05/form4-06182025_040608.xml | 0001415889-25-017698 | 5379 | ||||||
| 2025-06-18 | 4 | xslF345X05/form4-06182025_040606.xml | 0001415889-25-017697 | 5364 | ||||||
| 2025-06-18 | 4 | xslF345X05/form4-06182025_040603.xml | 0001415889-25-017696 | 5376 | ||||||
| 2025-06-18 | 4 | xslF345X05/form4-06182025_040601.xml | 0001415889-25-017695 | 5376 | ||||||
| 2025-05-22 | ARS | ARS | 0001628280-25-027149 | 001-38085 | 25974769 | 34 | 2014292 | |||
| 2025-05-22 | DEFA14A | DEFA14A | 0001628280-25-027148 | 001-38085 | 25974766 | 34 | 323914 | |||
| 2025-05-22 | DEF 14A | DEF 14A | 0001628280-25-027146 | 001-38085 | 25974763 | 34 | 3133755 | 1 | 1 | |
| 2025-05-13 | 10-Q | 10-Q | 0001628280-25-024913 | 001-38085 | 25937255 | 34 | 6719947 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02 | 0001628280-25-024911 | 001-38085 | 25937243 | 34 | 258163 | 1 | 1 |
| 2025-05-02 | 8-K | 8-K | 5.08 | 0001193125-25-111633 | 001-38085 | 25908701 | 34 | 147093 | 1 | 1 |
| 2025-05-02 | PRE 14A | PRE 14A | 0001628280-25-021830 | 001-38085 | 25908512 | 34 | 3144840 | 1 | 1 | |
| 2025-04-30 | 10-K/A | 10-K/A | 0001628280-25-021055 | 001-38085 | 25894979 | 34 | 980651 | 1 | 1 | |
| 2025-03-11 | 10-K | 10-K | 0001628280-25-011844 | 001-38085 | 25726023 | 34 | 15805833 | 1 | 1 | |
| 2025-03-11 | 8-K | 8-K | 2.02 | 0001628280-25-011839 | 001-38085 | 25725982 | 34 | 284147 | 1 | 1 |
| 2025-03-05 | 8-K | 8-K | 5.02 | 0001193125-25-047174 | 001-38085 | 25710988 | 34 | 149288 | 1 | 1 |
| 2025-03-04 | 4 | xslF345X05/form4-03042025_090327.xml | 0001415889-25-006568 | 5406 | ||||||
| 2025-03-04 | 3 | xslF345X02/form3-03042025_090338.xml | 0001415889-25-006566 | 10070 | ||||||
| 2025-02-28 | 4 | xslF345X05/form4-02282025_040204.xml | 0001415889-25-005998 | 5124 | ||||||
| 2025-02-28 | 4 | xslF345X05/form4-02282025_040201.xml | 0001415889-25-005997 | 5032 | ||||||
| 2025-02-24 | 4 | xslF345X05/form4-02242025_070206.xml | 0001415889-25-005368 | 5309 | ||||||
| 2025-02-24 | 4 | xslF345X05/form4-02242025_070203.xml | 0001415889-25-005367 | 7331 | ||||||
| 2025-02-24 | 4 | xslF345X05/form4-02242025_070201.xml | 0001415889-25-005366 | 7423 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001013594-25-000311 | 005-90350 | 25631366 | 34 | 13740 | |||
| 2025-02-13 | 8-K | 8-K | 3.01 | 0001193125-25-026192 | 001-38085 | 25621617 | 34 | 146852 | 1 | 1 |
| 2025-01-29 | 4 | xslF345X05/form4-01292025_020104.xml | 0001415889-25-002230 | 4593 | ||||||
| 2024-12-16 | 4 | xslF345X05/form4-12162024_041217.xml | 0001415889-24-029474 | 11179 | ||||||
| 2024-12-16 | 4 | xslF345X05/form4-12162024_041215.xml | 0001415889-24-029473 | 11158 | ||||||
| 2024-12-16 | 4 | xslF345X05/form4-12162024_041213.xml | 0001415889-24-029472 | 11172 | ||||||
| 2024-12-16 | 4 | xslF345X05/form4-12162024_041211.xml | 0001415889-24-029471 | 11166 | ||||||
| 2024-11-14 | SC 13G/A | ovid13ga3.htm | 0000935836-24-000717 | 005-90350 | 241464866 | 34 | 47000 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0000921895-24-002737 | 005-90350 | 241463518 | 34 | 276854 | |||
| 2024-11-12 | 10-Q | 10-Q | 0001628280-24-046868 | 001-38085 | 241443572 | 34 | 11550358 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 9.01 | 0001628280-24-046867 | 001-38085 | 241443530 | 34 | 263032 | 1 | 1 |
| 2024-09-11 | 4 | xslF345X05/form4-09112024_090958.xml | 0001415889-24-023237 | 5546 | ||||||
| 2024-09-11 | 3 | xslF345X02/form3-09112024_090933.xml | 0001415889-24-023235 | 19660 | ||||||
| 2024-09-11 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-217302 | 001-38085 | 241293170 | 34 | 273322 | 1 | 1 |
| 2024-08-13 | 10-Q | 10-Q | 0001628280-24-036860 | 001-38085 | 241198854 | 34 | 6506948 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 9.01 | 0001628280-24-036859 | 001-38085 | 241198850 | 34 | 264935 | 1 | 1 |
| 2024-08-02 | 8-K | 10-Q | 5.02 | 0001628280-24-034481 | 001-38085 | 241172286 | 34 | 154537 | 1 | 1 |
| 2024-08-01 | 4 | xslF345X05/form4-08012024_050801.xml | 0001415889-24-020526 | 11364 | ||||||
| 2024-07-01 | 8-K | 8-K | 8.01 | 0001628280-24-030546 | 001-38085 | 241088227 | 34 | 255229 | 1 | 1 |
| 2024-06-28 | 8-K | 8-K | 2.05,5.02,7.01 | 0001193125-24-172225 | 001-38085 | 241085487 | 34 | 153155 | 1 | 1 |
| 2024-06-17 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-073998 | 001-38085 | 241046936 | 34 | 248341 | 1 | 1 |
| 2024-06-07 | 8-K | 8-K | 5.07 | 0000950170-24-070673 | 001-38085 | 241029792 | 34 | 173822 | 1 | 1 |
| 2024-05-14 | S-8 | S-8 | 0001193125-24-138390 | 333-279405 | 24945799 | 33 | 70179 | |||
| 2024-05-14 | 10-Q | 10-Q | 0001628280-24-023067 | 001-38085 | 24941535 | 34 | 15539571 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-023064 | 001-38085 | 24941511 | 34 | 250794 | 1 | 1 |
| 2024-04-24 | ARS | ARS | 0000950170-24-047688 | 001-38085 | 24871357 | 34 | 2406120 | |||
| 2024-04-24 | DEFA14A | DEFA14A | 0000950170-24-047676 | 001-38085 | 24871338 | 34 | 1238104 | |||
| 2024-04-24 | DEF 14A | DEF 14A | 0000950170-24-047673 | 001-38085 | 24871330 | 34 | 6621737 | 1 | 1 | |
| 2024-03-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005001 | 6169 | ||||||
| 2024-03-08 | 10-K | 10-K | 0001628280-24-009809 | 001-38085 | 24732421 | 34 | 32171310 | 1 | 1 | |
| 2024-03-08 | 8-K | 8-K | 2.02 | 0001628280-24-009807 | 001-38085 | 24732415 | 34 | 275906 | 1 | 1 |
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003972 | 7651 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003970 | 7630 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003968 | 5426 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003966 | 7676 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003964 | 5407 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003962 | 5387 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003960 | 5405 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003958 | 5400 | ||||||
| 2024-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-24-003956 | 5401 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023663 | 005-90350 | 24638405 | 34 | 39932 | |||
| 2024-02-14 | 4/A | xslF345X05/form4a-02142024_040202.xml | 0001415889-24-003721 | 5667 | ||||||
| 2024-02-14 | SC 13G/A | ovid13ga-02142024.htm | 0001013594-24-000175 | 005-90350 | 24634195 | 34 | 103694 | |||
| 2024-02-12 | SC 13G/A | SC 13G/A | 0001104659-24-013559 | 005-90350 | 24617233 | 34 | 71462 | |||
| 2024-01-29 | SC 13G | us6904691010_012924.txt | 0001086364-24-005579 | 005-90350 | 24574882 | 34 | 13317 | |||
| 2023-12-06 | 8-K | 8-K | 8.01 | 0000950170-23-068591 | 001-38085 | 231470434 | 34 | 150481 | 1 | 1 |
| 2023-12-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-057640 | 7956 | ||||||
| 2023-11-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-11-15 16:00:00 | 9999999995-23-003334 | 333-275307 | 231412310 | 33 | 1682 | ||
| 2023-11-15 | 424B5 | 424B5 | 0001193125-23-277893 | 333-275307 | 231410673 | 33 | 477846 | |||
| 2023-11-13 | CORRESP | filename1.htm | 0001193125-23-275752 | 9055 | ||||||
| 2023-11-08 | UPLOAD | filename1.pdf | 0000000000-23-012266 | 40251 | ||||||
| 2023-11-03 | S-3 | S-3 | 0001193125-23-270373 | 333-275307 | 231376391 | 33 | 1489942 | |||
| 2023-11-03 | 10-Q | 10-Q | 0001628280-23-036564 | 001-38085 | 231374547 | 34 | 6555411 | 1 | 1 | |
| 2023-11-03 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-036563 | 001-38085 | 231374543 | 34 | 273894 | 1 | 1 |
| 2023-10-18 | 8-K | 8-K | 1.01,7.01,8.01,9.01 | 0000950170-23-053875 | 001-38085 | 231330945 | 34 | 225732 | 1 | 1 |
| 2023-10-02 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-050995 | 001-38085 | 231298570 | 34 | 52265080 | 1 | 1 |
| 2023-08-04 | 10-Q | 10-Q | 0001628280-23-027430 | 001-38085 | 231142397 | 34 | 6004177 | 1 | 1 | |
| 2023-08-04 | 8-K | 8-K | 2.02 | 0001628280-23-027426 | 001-38085 | 231142374 | 34 | 270703 | 1 | 1 |
| 2023-07-31 | SC 13G | ovid13g-07242023.htm | 0001013594-23-000620 | 005-90350 | 231128498 | 34 | 121155 | |||
| 2023-06-09 | 8-K | 8-K | 5.07 | 0000950170-23-027151 | 001-38085 | 231003982 | 34 | 221037 | 1 | 1 |
| 2023-05-05 | S-8 | S-8 | 0001193125-23-137265 | 333-271704 | 23895139 | 33 | 68185 | |||
| 2023-05-05 | 10-Q | 10-Q | 0001628280-23-016013 | 001-38085 | 23891581 | 34 | 5823641 | 1 | 1 | |
| 2023-05-05 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-015996 | 001-38085 | 23891390 | 34 | 285333 | 1 | 1 |
| 2023-05-01 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-016250 | 001-38085 | 23873925 | 34 | 252944 | 1 | 1 |
| 2023-04-27 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-015343 | 001-38085 | 23857899 | 34 | 239055 | 1 | 1 |
| 2023-04-27 | ARS | ARS | 0000950170-23-014924 | 001-38085 | 23851034 | 34 | 1894533 | |||
| 2023-04-27 | DEF 14A | DEF 14A | 0000950170-23-014914 | 001-38085 | 23851000 | 34 | 4885475 | |||
| 2023-04-26 | DEFA14A | DEFA14A | 0000950170-23-014910 | 001-38085 | 23850975 | 34 | 1755738 | |||
| 2023-03-13 | 10-K | 10-K | 0001628280-23-007648 | 001-38085 | 23725993 | 34 | 8002231 | 1 | 1 | |
| 2023-03-13 | 8-K | 8-K | 2.02 | 0001628280-23-007636 | 001-38085 | 23725804 | 34 | 291951 | 1 | 1 |
| 2023-03-10 | 8-K | 8-K | 7.01 | 0001628280-23-007568 | 001-38085 | 23724426 | 34 | 178121 | 1 | 1 |
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013309 | 5420 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013301 | 5404 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013251 | 5331 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013239 | 5445 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013236 | 5312 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013229 | 5292 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013215 | 5310 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013207 | 5305 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013203 | 5306 | ||||||
| 2023-02-14 | SC 13G/A | AMENDMENT TO FORM SC 13G | 0001839882-23-003736 | 005-90350 | 23628491 | 34 | 65203 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 4 TO THE SCHEDULE 13G | 0000921895-23-000480 | 005-90350 | 23620716 | 34 | 277145 | |||
| 2023-02-13 | SC 13G/A | ovid13ga.htm | 0000935836-23-000135 | 005-90350 | 23615463 | 34 | 60365 | |||
| 2023-02-10 | SC 13G | SC 13G | 0001104659-23-018479 | 005-90350 | 23611639 | 34 | 67031 | |||
| 2023-02-10 | SC 13G/A | ovid13ga.htm | 0000935836-23-000105 | 005-90350 | 23610592 | 34 | 47287 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016662 | 005-90350 | 23604001 | 34 | 12954 | |||
| 2023-02-03 | SC 13G/A | SC 13G/A | 0001395064-23-000010 | 005-90350 | 23584509 | 34 | 76574 | |||
| 2022-11-08 | 10-Q | 10-Q | 0001628280-22-028772 | 001-38085 | 221367404 | 34 | 6735232 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02 | 0001628280-22-028771 | 001-38085 | 221367400 | 34 | 297340 | 1 | 1 |
| 2022-09-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-049938 | 4869 | ||||||
| 2022-08-09 | 10-Q | 10-Q | 0001628280-22-021759 | 001-38085 | 221146530 | 34 | 6626489 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-021758 | 001-38085 | 221146521 | 34 | 290945 | 1 | 1 |
| 2022-07-06 | 4 | FORM 4 | 0001395064-22-000121 | 15446 | ||||||
| 2022-06-10 | 8-K | 8-K | 5.07 | 0000950170-22-011472 | 001-38085 | 221008814 | 34 | 196606 | 1 | 1 |
| 2022-05-11 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-009147 | 001-38085 | 22912149 | 34 | 183887 | 1 | 1 |
| 2022-05-10 | 10-Q | 10-Q | 0000950170-22-008739 | 001-38085 | 22907484 | 34 | 8037061 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008734 | 001-38085 | 22907459 | 34 | 408557 | 1 | 1 |
| 2022-05-02 | DEFA14A | DEFA14A | 0000950170-22-006763 | 001-38085 | 22879297 | 34 | 458880 | |||
| 2022-04-29 | DEF 14A | DEF 14A | 0000950170-22-006707 | 001-38085 | 22875054 | 34 | 1580893 | |||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024198 | 5455 | ||||||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024191 | 7953 | ||||||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024189 | 5354 | ||||||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024187 | 7943 | ||||||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024185 | 7975 | ||||||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024163 | 5468 | ||||||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024159 | 5469 | ||||||
| 2022-03-16 | S-8 POS | S-8 POS | 0001193125-22-077218 | 333-263562 | 22744837 | 33 | 36747 | |||
| 2022-03-15 | S-8 | S-8 | 0001193125-22-076005 | 333-263562 | 22741029 | 33 | 74053 | |||
| 2022-03-15 | 10-K | 10-K | 0000950170-22-003668 | 001-38085 | 22739232 | 34 | 10574352 | 1 | 1 | |
| 2022-03-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-003665 | 001-38085 | 22739213 | 34 | 345858 | 1 | 1 |
| 2022-02-14 | SC 13G/A | AMENDMENT TO FORM SC 13G | 0001839882-22-002943 | 005-90350 | 22635227 | 34 | 56054 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-22-001913 | 005-90350 | 22633012 | 34 | 69522 | |||
| 2022-02-14 | SC 13G/A | ovidtherapeutics13ga.htm | 0000935836-22-000167 | 005-90350 | 22630396 | 34 | 47242 | |||
| 2022-02-14 | SC 13G/A | ovidtherapeutics13ga.htm | 0000935836-22-000108 | 005-90350 | 22623162 | 34 | 60714 | |||
| 2022-02-10 | SC 13G | SCHEDULE 13G | 0001104659-22-018273 | 005-90350 | 22610582 | 34 | 12924 | |||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007329 | 5340 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007328 | 5301 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007327 | 5319 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007326 | 5314 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007325 | 5315 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007314 | 5429 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007311 | 5413 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007310 | 5454 | ||||||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007305 | 5321 | ||||||
| 2022-01-03 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001564590-22-000016 | 001-38085 | 22500367 | 34 | 916498 | 1 | 1 |
| 2021-11-10 | 10-Q | 10-Q | 0000950170-21-004066 | 001-38085 | 211396454 | 34 | 9260988 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-21-325375 | 001-38085 | 211394580 | 34 | 234024 | 1 | 1 |
| 2021-10-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-059940 | 5517 | ||||||
| 2021-10-07 | 3 | FORM 3 SUBMISSION | 0001209191-21-059929 | 2930 | ||||||
| 2021-10-07 | 8-K | 8-K | 5.02 | 0001564590-21-050376 | 001-38085 | 211311119 | 34 | 167000 | 1 | 1 |
| 2021-08-18 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-044971 | 001-38085 | 211185047 | 34 | 7160738 | 1 | 1 |
| 2021-08-16 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-044455 | 001-38085 | 211174626 | 34 | 1456421 | ||
| 2021-08-16 | 10-Q | 10-Q | 0000950170-21-001457 | 001-38085 | 211173560 | 34 | 8200561 | 1 | 1 | |
| 2021-08-11 | 8-K/A | 8-K/A | 5.02 | 0001564590-21-043544 | 001-38085 | 211164737 | 34 | 30289 | ||
| 2021-07-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-046995 | 9106 | ||||||
| 2021-07-13 | 4 | FORM 4 SUBMISSION | 0001209191-21-046497 | 9788 | ||||||
| 2021-07-12 | 3 | FORM 3 SUBMISSION | 0001209191-21-046304 | 7269 | ||||||
| 2021-07-12 | SC 13G | us6904691010_071021.txt | 0000834237-21-008766 | 005-90350 | 211084439 | 34 | 12173 | |||
| 2021-07-08 | 8-K | 8-K | 5.02 | 0001564590-21-036074 | 001-38085 | 211080564 | 34 | 29453 | ||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-044391 | 5424 | ||||||
| 2021-06-23 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-033909 | 001-38085 | 211037219 | 34 | 6409593 | ||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-040081 | 5312 | ||||||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-040075 | 5299 | ||||||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-040069 | 5313 | ||||||
| 2021-06-11 | 8-K | 8-K | 5.07 | 0001564590-21-032652 | 001-38085 | 211011279 | 34 | 41189 | ||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-039670 | 5431 | ||||||
| 2021-06-04 | 8-K | 8-K | 5.02 | 0001564590-21-031677 | 001-38085 | 21994900 | 34 | 31049 | ||
| 2021-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-033831 | 5290 | ||||||
| 2021-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-033829 | 5295 | ||||||
| 2021-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-033828 | 5314 | ||||||
| 2021-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-033825 | 5309 | ||||||
| 2021-05-18 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-028670 | 001-38085 | 21935709 | 34 | 5618066 | ||
| 2021-05-13 | 10-Q | 10-Q | 0001564590-21-027623 | 001-38085 | 21920535 | 34 | 6526929 | 1 | ||
| 2021-05-13 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-027612 | 001-38085 | 21920309 | 34 | 124681 | ||
| 2021-04-30 | DEFA14A | DEFA14A | 0001564590-21-022436 | 001-38085 | 21876656 | 34 | 534400 | |||
| 2021-04-30 | DEF 14A | DEF 14A | 0001564590-21-022189 | 001-38085 | 21873473 | 34 | 1203550 | |||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-029048 | 5711 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-029041 | 5687 | ||||||
| 2021-04-29 | SC 13G | ovid13g.htm | 0000935836-21-000342 | 005-90350 | 21871548 | 34 | 61847 | |||
| 2021-04-19 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-019420 | 001-38085 | 21834872 | 34 | 5652449 | ||
| 2021-04-19 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-019260 | 001-38085 | 21833308 | 34 | 90423 | ||
| 2021-04-15 | SC 13G/A | AMENDMENT NO. 3 TO THE SCHEDULE 13G | 0000921895-21-001066 | 005-90350 | 21828596 | 34 | 279622 | |||
| 2021-04-09 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-018257 | 001-38085 | 21816774 | 34 | 5862619 | ||
| 2021-04-01 | 8-K | 8-K | 1.02 | 0001564590-21-017335 | 001-38085 | 21798828 | 34 | 26485 | ||
| 2021-03-30 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-016325 | 001-38085 | 21783704 | 34 | 90692 | ||
| 2021-03-18 | CT ORDER | filename1.pdf | 20210318,20210318 | 9999999997-21-001227 | 001-38085 | 21753126 | 34 | 123028 | ||
| 2021-03-18 | S-8 | S-8 | 0001193125-21-084391 | 333-254420 | 21752540 | 33 | 59532 | |||
| 2021-03-15 | 10-K | 10-K 2020 | 0001564590-21-013016 | 001-38085 | 21739912 | 34 | 10727885 | 1 | ||
| 2021-03-15 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-013010 | 001-38085 | 21739887 | 34 | 155565 | ||
| 2021-03-09 | SC 13G/A | ovidthera13g.htm | 0000935836-21-000231 | 005-90350 | 21725268 | 34 | 48266 | |||
| 2021-03-09 | SC 13G | ovidthera13g.htm | 0000935836-21-000227 | 005-90350 | 21725042 | 34 | 48262 | |||
| 2021-03-03 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-010454 | 001-38085 | 21707492 | 34 | 992251 | ||
| 2021-03-03 | 8-K | 8-K | 1.01,1.02 | 0001564590-21-010415 | 001-38085 | 21707206 | 34 | 31628 | ||
| 2021-02-17 | SC 13G/A | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-21-001039 | 005-90350 | 21644263 | 34 | 55042 | |||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001193125-21-045021 | 005-90350 | 21639635 | 34 | 34901 | |||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001193125-21-045008 | 005-90350 | 21639577 | 34 | 39637 | |||
| 2021-02-16 | SC 13G/A | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-21-000929 | 005-90350 | 21636235 | 34 | 55131 | |||
| 2021-02-12 | SC 13G/A | AMENDMENT NO. 2 TO THE SCHEDULE 13G | 0000921895-21-000381 | 005-90350 | 21627737 | 34 | 280341 | |||
| 2021-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-008642 | 5539 | ||||||
| 2021-02-02 | SC 13G | us6904691010_020221.txt | 0000834237-21-007063 | 005-90350 | 21580803 | 34 | 13120 | |||
| 2021-01-05 | SC 13G/A | SCHEDULE 13G/A | 0001170316-21-000003 | 005-90350 | 21505099 | 34 | 5434 | |||
| 2020-12-21 | 8-K | 8-K | 5.02 | 0001564590-20-057864 | 001-38085 | 201405195 | 34 | 41510 | ||
| 2020-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-064678 | 5432 | ||||||
| 2020-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-064674 | 5456 | ||||||
| 2020-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-064666 | 5433 | ||||||
| 2020-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-064665 | 5475 | ||||||
| 2020-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-064657 | 5323 | ||||||
| 2020-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-064649 | 5491 | ||||||
| 2020-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-064645 | 5446 | ||||||
| 2020-12-01 | 8-K | 8-K | 8.01,9.01 | 0001564590-20-055762 | 001-38085 | 201361687 | 34 | 58419 | ||
| 2020-11-20 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-11-20 16:00:00 | 9999999995-20-003262 | 333-250054 | 201334175 | 33 | 1702 | ||
| 2020-11-20 | 424B5 | 424B5 | 0001193125-20-299425 | 333-250054 | 201332799 | 33 | 524018 | |||
| 2020-11-18 | CORRESP | filename1.htm | 0001193125-20-297059 | 8577 | ||||||
| 2020-11-18 | UPLOAD | filename1.pdf | 0000000000-20-011034 | 40211 | ||||||
| 2020-11-13 | S-3 | S-3 | 0001193125-20-292202 | 333-250054 | 201309086 | 33 | 1682442 | |||
| 2020-11-13 | 10-Q | 10-Q | 0001564590-20-053666 | 001-38085 | 201308411 | 34 | 7767738 | 1 | ||
| 2020-11-12 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-053607 | 001-38085 | 201307172 | 34 | 151469 | ||
| 2020-10-22 | 8-K | 8-K | 7.01,9.01 | 0001564590-20-047230 | 001-38085 | 201253521 | 34 | 31282330 | ||
| 2020-10-13 | 4 | FORM 4 SUBMISSION | 0001209191-20-054653 | 5426 | ||||||
| 2020-10-13 | 4 | FORM 4 SUBMISSION | 0001209191-20-054645 | 5484 | ||||||
| 2020-10-13 | 4 | FORM 4 SUBMISSION | 0001209191-20-054642 | 5449 | ||||||
| 2020-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-053411 | 9230 | ||||||
| 2020-10-02 | 3 | FORM 3 SUBMISSION | 0001209191-20-053404 | 7246 | ||||||
| 2020-09-30 | 8-K | 8-K | 8.01,9.01 | 0001564590-20-045189 | 001-38085 | 201210657 | 34 | 86966 | ||
| 2020-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-20-049011 | 5524 | ||||||
| 2020-08-26 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-231250 | 001-38085 | 201137321 | 34 | 258551 | ||
| 2020-08-26 | 424B5 | 424B5 | 0001193125-20-231241 | 333-225391 | 201137277 | 33 | 1058043 | |||
| 2020-08-25 | 8-K | 8-K | 8.01,9.01 | 0001564590-20-041092 | 001-38085 | 201129544 | 34 | 10112763 | ||
| 2020-08-10 | 10-Q | 10-Q | 0001564590-20-038644 | 001-38085 | 201087226 | 34 | 6512906 | 1 | ||
| 2020-08-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-038634 | 001-38085 | 201087188 | 34 | 183514 | ||
| 2020-07-13 | 8-K | 8-K | 1.01 | 0001564590-20-032209 | 001-38085 | 201024287 | 34 | 31859 | ||
| 2020-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-20-038475 | 5534 | ||||||
| 2020-06-19 | 8-K | 8-K | 8.01,9.01 | 0001564590-20-029856 | 001-38085 | 20974304 | 34 | 54024 | ||
| 2020-06-17 | 8-K | 8-K | 7.01,9.01 | 0001564590-20-029613 | 001-38085 | 20969062 | 34 | 17710840 | ||
| 2020-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-20-035041 | 5293 | ||||||
| 2020-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-20-035040 | 5298 | ||||||
| 2020-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-20-035039 | 5314 | ||||||
| 2020-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-20-035038 | 5312 | ||||||
| 2020-06-05 | 8-K | 8-K | 5.07 | 0001564590-20-028515 | 001-38085 | 20947207 | 34 | 44861 | ||
| 2020-05-27 | SC 13D/A | efc19-628_sc13d1227.htm | 0001768824-20-000003 | 005-90350 | 20914046 | 34 | 185390 | |||
| 2020-05-13 | SC 13D/A | efc19-628_sc13d1227.htm | 0001768824-20-000001 | 005-90350 | 20872587 | 34 | 185547 | |||
| 2020-05-07 | 10-Q | 10-Q | 0001564590-20-023002 | 001-38085 | 20857600 | 34 | 5670578 | 1 | ||
| 2020-05-07 | 8-K | 8-K | 2.02,8.01,9.01 | 0001564590-20-022392 | 001-38085 | 20854667 | 34 | 215282 | ||
| 2020-04-24 | DEFA14A | DEFA14A | 0001564590-20-018286 | 001-38085 | 20812066 | 34 | 241149 | |||
| 2020-04-24 | DEF 14A | DEF 14A | 0001564590-20-018268 | 001-38085 | 20811997 | 34 | 1171982 | |||
| 2020-03-30 | 8-K | 8-K | 8.01,9.01 | 0001564590-20-013857 | 001-38085 | 20754072 | 34 | 70121 | ||
| 2020-03-27 | SC 13G/A | SCHEDULE 13G | 0001170316-20-000003 | 005-90350 | 20748206 | 34 | 5428 | |||
| 2020-03-13 | 8-K | 8-K | 7.01,9.01 | 0001564590-20-010659 | 001-38085 | 20710867 | 34 | 11153901 | ||
| 2020-03-11 | S-8 | S-8 | 0001193125-20-070452 | 333-237098 | 20706341 | 33 | 60048 | |||
| 2020-03-11 | 10-K | 10-K 2019 | 0001564590-20-010108 | 001-38085 | 20705899 | 34 | 9077019 | 1 | ||
| 2020-03-11 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-009878 | 001-38085 | 20703913 | 34 | 144667 | ||
| 2020-03-02 | 8-K | 8-K | 7.01,9.01 | 0001564590-20-008128 | 001-38085 | 20676611 | 34 | 11155263 | ||
| 2020-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-20-000516 | 005-90350 | 20618094 | 34 | 296201 | |||
| 2020-02-14 | SC 13G | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-20-000790 | 005-90350 | 20617852 | 34 | 57225 | |||
| 2020-02-14 | SC 13G/A | d8478272_13g-a.htm | 0000919574-20-001524 | 005-90350 | 20617375 | 34 | 115551 | |||
| 2020-02-14 | SC 13G/A | SC 13G/A | 0001193125-20-036949 | 005-90350 | 20614599 | 34 | 35997 | |||
| 2020-02-14 | SC 13G/A | SC 13G/A | 0001193125-20-036944 | 005-90350 | 20614565 | 34 | 35550 | |||
| 2020-01-17 | SC 13G/A | SCHEDULE 13G | 0001170316-20-000002 | 005-90350 | 20533539 | 34 | 5637 | |||
| 2020-01-07 | 8-K | 8-K | 8.01,9.01 | 0001564590-20-000319 | 001-38085 | 20512133 | 34 | 69040 | ||
| 2020-01-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-000452 | 5450 | ||||||
| 2019-12-24 | 8-K | 8-K | 5.02 | 0001564590-19-046730 | 001-38085 | 191307600 | 34 | 44613 | ||
| 2019-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-19-061568 | 5475 | ||||||
| 2019-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-19-061560 | 5322 | ||||||
| 2019-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-19-061548 | 5491 | ||||||
| 2019-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-19-061544 | 5450 | ||||||
| 2019-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-19-061538 | 5450 | ||||||
| 2019-11-27 | SC 13D/A | AMENDMENT 2 | 0001768824-19-000008 | 005-90350 | 191255841 | 34 | 197829 | |||
| 2019-11-22 | 4 | FORM 4 | 0001395064-19-000083 | 7472 | ||||||
| 2019-11-22 | SC 13G/A | SC 13G/A | 0001395064-19-000082 | 005-90350 | 191238659 | 34 | 88296 | |||
| 2019-11-22 | 3 | FORM 3 | 0001395064-19-000081 | 9148 | ||||||
| 2019-11-22 | SC 13G/A | SC 13G/A | 0001395064-19-000080 | 005-90350 | 191238652 | 34 | 88689 | |||
| 2019-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-19-057557 | 5432 | ||||||
| 2019-11-21 | 3 | FORM 3 SUBMISSION | 0001209191-19-057556 | 2947 | ||||||
| 2019-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-19-056750 | 5296 | ||||||
| 2019-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-19-056745 | 5301 | ||||||
| 2019-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-19-056741 | 5320 | ||||||
| 2019-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-19-056735 | 5315 | ||||||
| 2019-11-12 | 424B5 | 424B5 | 0001193125-19-289308 | 333-225391 | 191206233 | 33 | 444691 | |||
| 2019-11-08 | 10-Q | 10-Q | 0001564590-19-042028 | 001-38085 | 191202184 | 34 | 6407925 | 1 | ||
| 2019-11-08 | 8-K | 8-K | 2.02,9.01 | 0001564590-19-042022 | 001-38085 | 191202158 | 34 | 174717 | ||
| 2019-11-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-055002 | 5471 | ||||||
| 2019-11-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-055000 | 5454 | ||||||
| 2019-11-01 | 8-K | 8-K | 5.01,8.01,9.01 | 0001564590-19-039281 | 001-38085 | 191185245 | 34 | 54883 | ||
| 2019-10-10 | 4 | FORM 4 SUBMISSION | 0001209191-19-052988 | 6998 | ||||||
| 2019-10-08 | 424B5 | 424B5 | 0001193125-19-263978 | 333-225391 | 191141751 | 33 | 1407310 | |||
| 2019-10-08 | 424B5 | 424B5 | 0001193125-19-263977 | 333-225391 | 191141749 | 33 | 1388421 | |||
| 2019-10-08 | 8-K | FORM 8-K | 8.01,9.01 | 0001193125-19-263976 | 001-38085 | 191141744 | 34 | 461685 | ||
| 2019-10-07 | SC 13D/A | efc19-628_sc13da.htm | 0001768824-19-000006 | 005-90350 | 191140442 | 34 | 194097 | |||
| 2019-10-03 | 424B5 | 424B5 | 0001193125-19-261653 | 333-225391 | 191135692 | 33 | 1408615 | |||
| 2019-10-03 | 424B5 | 424B5 | 0001193125-19-261644 | 333-225391 | 191135638 | 33 | 1390903 | |||
| 2019-09-24 | 8-K | 8-K | 5.03,9.01 | 0001564590-19-035235 | 001-38085 | 191109095 | 34 | 185115 | ||
| 2019-09-23 | 8-K | 8-K | 7.01,8.01,9.01 | 0001564590-19-035162 | 001-38085 | 191106277 | 34 | 7796885 | ||
| 2019-09-19 | 8-K | FORM 8-K | 3.02,5.03,5.07,9.01 | 0001193125-19-248745 | 001-38085 | 191100903 | 34 | 153063 | ||
| 2019-09-12 | 8-K | 8-K | 8.01,9.01 | 0001564590-19-034545 | 001-38085 | 191089544 | 34 | 55885 | ||
| 2019-09-09 | 8-K | 8-K | 8.01,9.01 | 0001564590-19-034294 | 001-38085 | 191080549 | 34 | 15034409 | ||
| 2019-08-07 | S-8 | S-8 | 0001193125-19-215523 | 333-233101 | 191006581 | 33 | 73073 | |||
| 2019-08-07 | 10-Q | Q2 10-Q | 0001564590-19-030178 | 001-38085 | 191006304 | 34 | 6035413 | 1 | ||
| 2019-08-07 | 8-K | 8-K | 2.02,9.01 | 0001564590-19-030143 | 001-38085 | 191006064 | 34 | 155781 | ||
| 2019-08-02 | 4 | FORM 4 SUBMISSION | 0001209191-19-044363 | 5292 | ||||||
| 2019-08-01 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-044055 | 5641 | ||||||
| 2019-08-01 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-044050 | 5662 | ||||||
| 2019-08-01 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-044045 | 5660 | ||||||
| 2019-07-02 | 8-K | 8-K | 8.01,9.01 | 0001564590-19-024285 | 001-38085 | 19935295 | 34 | 54914 | ||
| 2019-06-27 | 8-K | 8-K | 7.01,9.01 | 0001564590-19-023703 | 001-38085 | 19923746 | 34 | 33517684 | ||
| 2019-06-27 | 8-K | 8-K | 8.01,9.01 | 0001564590-19-023666 | 001-38085 | 19922987 | 34 | 74427 | ||
| 2019-06-18 | 8-K | 8-K | 8.01,9.01 | 0001564590-19-022718 | 001-38085 | 19902688 | 34 | 48609 | ||
| 2019-06-17 | 8-K/A | 8-K/A | 1.01,9.01 | 0001564590-19-022662 | 001-38085 | 19901715 | 34 | 73025 | ||
| 2019-06-10 | 8-K | 8-K | 5.07 | 0001564590-19-022139 | 001-38085 | 19889367 | 34 | 41587 | ||
| 2019-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-19-035795 | 5289 | ||||||
| 2019-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-19-035786 | 5307 | ||||||
| 2019-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-19-035784 | 5305 |
One latest value per concept from companyfacts (283 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 188.73M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 22.20M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.40M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001628280-26-027621 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 995,718 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001628280-26-027621 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 3.73M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001628280-26-027621 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.93M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001628280-26-027621 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 87.63 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001628280-26-027621 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 1,045.74 | 2026-11-09 | S-3 | 2026-11-10 | 0001193125-26-454506 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 1,045.74 | 2026-11-09 | S-3 | 2026-11-10 | 0001193125-26-454506 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 250.00M | 2026-11-09 | S-3 | 2026-11-10 | 0001193125-26-454506 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-09 | S-3 | 2026-11-10 | 0001193125-26-454506 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-09 | S-3 | 2026-11-10 | 0001193125-26-454506 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AccountsReceivableRelatedParties | Accounts Receivable, Related Parties | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | AccruedIncomeTaxes | Accrued Income Taxes | USD | 129,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 4.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 670,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 574.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 356.08M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.28M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 52.51M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | Assets | Assets | USD | 222.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 141.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 653,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 148.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 5.00M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006804 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 147.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 122.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 24.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004066 |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year | Investment | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006804 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001628280-22-021759 |
| us-gaap | Cash | Cash | USD | 3.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 13.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 166.67M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008739 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 10.87M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030178 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 161.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 15.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -5.69M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001636651-25-000012 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 658,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 10.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.91 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 315.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 188.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 188.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 189,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -53.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 718,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001636651-25-000012 | |
| us-gaap | CostOfGoodsAndServicesSoldDepreciationAndAmortization | Cost, Depreciation and Amortization | USD | 66,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004066 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001628280-22-021759 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | Investment | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 5.00M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-11 | 0001564590-20-010108 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | 223,649 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001628280-22-021759 |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 242,673 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 5.80M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013016 |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 500,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001564590-21-027623 |
| us-gaap | DeferredTaxAssetsCharitableContributionCarryforwards | Deferred Tax Assets, Charitable Contribution Carryforwards | USD | 2,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 4.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 92.63M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-08 | 0001628280-24-009809 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 70.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 2.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation | USD | 28,243 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 5.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 97,494 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-08 | 0001628280-24-009809 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 91.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 2.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 5.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 48,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 172,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | Depreciation | Depreciation | USD | 66,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 66,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | Dividends | Dividends | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 7,369 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | DueToRelatedPartiesNoncurrent | Due to Related Parties, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.24 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.35 | 2019-10-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-11 | 0001564590-20-010108 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.24 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.111 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011844 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0.011 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004066 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount | EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent | EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.003 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011844 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.013 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-08 | 0001628280-24-009809 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.068 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011844 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | -194,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 13.50M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001628280-26-033864 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 9.50M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001636651-25-000012 | |
| us-gaap | EquityMethodInvestmentOtherThanTemporaryImpairment | Equity Method Investment, Other than Temporary Impairment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011844 |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 5.10M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 | |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | EquitySecuritiesFvNiUnrealizedLoss | Equity Securities, FV-NI, Unrealized Loss | USD | 1.30M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011844 |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueAmount | Equity Securities without Readily Determinable Fair Value, Amount | USD | 42.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | FairValueOptionChangesInFairValueGainLoss1 | Fair Value, Option, Changes in Fair Value, Gain (Loss) | USD | -872,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | GainContingencyUnrecordedAmount | Gain Contingency, Unrecorded Amount | USD | 1.80M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011844 | |
| us-gaap | GainLossOnDispositionOfIntangibleAssets | Gain (Loss) on Disposition of Intangible Assets | USD | -4,610 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-11 | 0001564590-20-010108 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 19.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -17.77M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -52.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 361,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -3.66M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 7,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.19M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -52,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | IncreaseDecreaseDueFromAffiliates | Increase (Decrease) Due from Affiliates | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 3.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -409,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | 229,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006804 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncreaseDecreaseInDueFromRelatedParties | Increase (Decrease) in Due from Related Parties | USD | -7,369 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006804 |
| us-gaap | IncreaseDecreaseInDueToRelatedParties | Increase (Decrease) in Due to Related Parties | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 604,646 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 624,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | IncreaseDecreaseInPrepaidRent | Increase (Decrease) in Prepaid Rent | USD | -12,338 | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023274 |
| us-gaap | IncreaseDecreaseInSecurityDeposits | Increase (Decrease) in Security Deposits | USD | 56,943 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 565,538 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004066 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 3.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | LandSubjectToGroundLeases | Land Subject to Ground Leases | sqft | 19,000 | 2022-03-10 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 15.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 4.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 2.47M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 579,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | Liabilities | Liabilities | USD | 23.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 222.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 11.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 20.91M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001636651-25-000012 | |
| us-gaap | LossContingencyLossInPeriod | Loss Contingency, Loss in Period | USD | 1.80M | 2024-07-01 | 2024-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 36.70M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-03 | 0001628280-23-036564 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 117.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 75,401 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011934 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -69.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -45.07M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011934 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -47.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -12.93M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011934 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -52.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -17.18M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -17.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification | New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 854,786 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-10 | 0001564590-20-038644 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 56.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -55.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 16.25M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 10.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 2.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 10.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 954,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 56,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent | USD | -277,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -192,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -2,469 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -633,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OtherNoncashIncome | Other Noncash Income | USD | 733,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 3.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 711,009 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 |
| us-gaap | ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic | Participating Securities, Distributed and Undistributed Earnings (Loss), Basic | USD | -272,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted | Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted | USD | -458,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 505,229 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-06-13 | 0001193125-17-202470 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 2.30M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-08 | 0001628280-24-009809 |
| us-gaap | PaymentsForSoftware | Payments for Software | USD | 40,439 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-06-13 | 0001193125-17-202470 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 110.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | PaymentsToAcquireEquityMethodInvestments | Payments to Acquire Equity Method Investments | USD | 1.63M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 |
| us-gaap | PaymentsToAcquireLongtermInvestments | Payments to Acquire Long-term Investments | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011844 |
| us-gaap | PaymentsToAcquireNotesReceivable | Payments to Acquire Notes Receivable | USD | 1.00M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001628280-22-021759 |
| us-gaap | PaymentsToAcquireProductiveAssets | Payments to Acquire Productive Assets | USD | 5,895 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030178 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | PaymentsToDevelopSoftware | Payments to Develop Software | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.08 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 5.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 69.75M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006804 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 10.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 70.64M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 56.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 73,104 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030178 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 46.70M | 2020-08-01 | 2020-08-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001564590-21-027623 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003668 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 41.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ProceedsFromSaleOfLongtermInvestments | Proceeds from Sale of Long-term Investments | USD | 70,000 | 2025-02-01 | 2025-02-28 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 667,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 168,577 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 50.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 186,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | USD | 750,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008739 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 36.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 1.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | eliminated | 17 | 2024-04-01 | 2024-06-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.43 | 2024-04-01 | 2024-06-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -374.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 735,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 1.46M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-08 | 0001628280-24-009809 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 700,000 | 2025-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 39,091 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 2.98M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-06-13 | 0001193125-17-202470 |
| us-gaap | SettlementLiabilitiesCurrent | Settlement Liabilities, Current | USD | 750,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008739 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 893,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 3.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 4.44M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023274 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.56M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023274 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 7.64 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023274 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 324,312 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 1.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 4.44 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 2.37M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 7.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 14.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 22.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 2.35 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 5.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 12.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 2.91 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 10.75M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023274 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 50,000 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0000950170-21-001457 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 8.04 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023274 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 1.04M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-06-13 | 0001193125-17-202470 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.05 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 5.56 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.89 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 198.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.465 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 576,460 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 0 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 15,000 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072495 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 46.73M | 2020-07-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004066 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 4.01M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-29 | 0001564590-18-007152 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 7.30M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-13 | 0001628280-23-007648 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 81,629 | 2022-07-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 21.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 1.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-18 | 0001628280-26-019438 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001628280-26-033864 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028772 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 70.87M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 24.63M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006804 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 70.87M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-046868 |